Olympiad Research LP Takes $360,000 Position in Option Care Health, Inc. (NASDAQ:OPCH)

Olympiad Research LP purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 15,520 shares of the company's stock, valued at approximately $360,000.

Several other institutional investors have also added to or reduced their stakes in the company. Creative Planning boosted its position in shares of Option Care Health by 116.7% during the 3rd quarter. Creative Planning now owns 38,149 shares of the company's stock valued at $1,194,000 after acquiring an additional 20,546 shares during the last quarter. Blue Trust Inc. increased its holdings in shares of Option Care Health by 37.2% in the 3rd quarter. Blue Trust Inc. now owns 4,022 shares of the company's stock worth $126,000 after buying an additional 1,091 shares during the last quarter. Raymond James & Associates lifted its holdings in shares of Option Care Health by 6.3% in the 3rd quarter. Raymond James & Associates now owns 85,279 shares of the company's stock valued at $2,669,000 after acquiring an additional 5,049 shares during the last quarter. International Assets Investment Management LLC lifted its holdings in shares of Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock valued at $91,000 after acquiring an additional 2,757 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC purchased a new position in Option Care Health in the third quarter worth about $206,000. Hedge funds and other institutional investors own 98.05% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of equities research analysts have issued reports on OPCH shares. JMP Securities restated a "market outperform" rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. UBS Group initiated coverage on Option Care Health in a research report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price target for the company. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research increased their target price on shares of Option Care Health from $32.00 to $33.00 and gave the company an "outperform" rating in a research note on Tuesday, January 14th. Finally, Truist Financial dropped their price target on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research note on Friday, November 1st. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $32.25.

Option Care Health Trading Up 1.6 %

OPCH traded up $0.52 on Wednesday, reaching $33.15. 3,231,004 shares of the company traded hands, compared to its average volume of 1,784,016. The company has a market cap of $5.64 billion, a P/E ratio of 27.86, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.17. The firm has a fifty day simple moving average of $28.07 and a two-hundred day simple moving average of $28.00.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.33 by $0.02. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. As a group, equities research analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.